A Novel Oral GyrB/ParE Dual Binding Inhibitor Effective against Multidrug-Resistant Neisseria gonorrhoeae and Other High-Threat Pathogens

Authors:

Abstract
Drug-resistant Neisseria gonorrhoeae is a serious global health concern. New drugs are needed that can overcome existing drug resistance and limit the development of new resistances.
All Related Versions
Funding Information
  • HHS | National Institutes of Health (U19AI109713)

This publication has 41 references indexed in Scilit: